Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1 J Stitz, CJ Buchholz, M Engelstädter, W Uckert, U Bloemer, I Schmitt, ... Virology 273 (1), 16-20, 2000 | 190 | 2000 |
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells BS Schnierle, J Stitz, V Bosch, F Nocken, H Merget-Millitzer, ... Proceedings of the National Academy of Sciences 94 (16), 8640-8645, 1997 | 171 | 1997 |
Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library M Engelstadter, M Bobkova, M Baier, J Stitz, N Holtkamp, THT Chu, ... Human gene therapy 11 (2), 293-303, 2000 | 71 | 2000 |
Identification of R-peptides in envelope proteins of C-type retroviruses M Bobkova, J Stitz, M Engelstädter, K Cichutek, CJ Buchholz Journal of General Virology 83 (9), 2241-2246, 2002 | 63 | 2002 |
Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine. Y van Heuvel, S Schatz, JF Rosengarten, J Stitz Toxins 2022, 14, 138, 2022 | 45 | 2022 |
A novel lentivirus vector derived from apathogenic simian immunodeficiency virus J Stitz, MD Mühlebach, U Blömer, M Scherr, M Selbert, P Wehner, S Steidl, ... Virology 291 (2), 191-197, 2001 | 42 | 2001 |
Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles CA Merten, J Stitz, G Braun, EM Poeschla, K Cichutek, CJ Buchholz Journal of virology 79 (2), 834-840, 2005 | 40 | 2005 |
Retroviral cell targeting vectors. CJ Buchholz, J Stitz, K Cichutek Current Opinion in Molecular Therapeutics 1 (5), 613-621, 1999 | 39 | 1999 |
Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins M Engelstädter, CJ Buchholz, M Bobkova, S Steidl, H Merget-Millitzer, ... Gene therapy 8 (15), 1202-1206, 2001 | 34 | 2001 |
Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes MD Mühlebach, I Schmitt, S Steidl, J Stitz, M Schweizer, T Blankenstein, ... Journal of molecular medicine 81, 801-810, 2003 | 27 | 2003 |
Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof JPM Langedijk, D Van Manen, J Vellinga, F Wegmann, BCS Callendret, ... US Patent 10,369,214, 2019 | 23 | 2019 |
MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients J Stitz, S Steidl, H Merget-Millitzer, R König, P Müller, F Nocken, ... Virology 267 (2), 229-236, 2000 | 23 | 2000 |
Coreceptor Switch of [MLV (SIVagm)] pseudotype vectors by V3-loop exchange S Steidl, J Stitz, I Schmitt, R König, E Flory, M Schweizer, K Cichutek Virology 300 (2), 205-216, 2002 | 22 | 2002 |
Process design and optimization towards digital twins for HIV-gag VLP production in HEK293 cells, including purification H Helgers, A Hengelbrock, A Schmidt, J Rosengarten, J Stitz, J Strube Processes 10 (2), 419, 2022 | 21 | 2022 |
Digital twin for HIV-gag VLP production in HEK293 cells A Hengelbrock, H Helgers, A Schmidt, FL Vetter, A Juckers, ... Processes 10 (5), 866, 2022 | 20 | 2022 |
Screening of retroviral cDNA libraries for factors involved in protein phosphorylation in signaling cascades J Stitz, PO Krutzik, GP Nolan Nucleic acids research 33 (4), e39-e39, 2005 | 19 | 2005 |
Transposon vector-mediated stable gene transfer for the accelerated establishment of recombinant mammalian cell pools allowing for high-yield production of biologics N Tschorn, K Berg, J Stitz Biotechnology Letters 42, 1103-1112, 2020 | 18 | 2020 |
Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes JF Rosengarten, S Schatz, T Wolf, S Barbe, J Stitz Virology 568, 41-48, 2022 | 17 | 2022 |
Displaying tetra‐membrane spanning Claudins on enveloped virus‐like particles for cancer immunotherapy IC Schneider, J Hartmann, G Braun, J Stitz, T Klamp, M Bihi, U Sahin, ... Biotechnology Journal 13 (3), 1700345, 2018 | 16 | 2018 |
Rapid establishment of stable retroviral packaging cells and recombinant susceptible target cell lines employing novel transposon vectors derived from Sleeping Beauty K Berg, VN Schäfer, N Bartnicki, R Eggenschwiler, T Cantz, J Stitz Virology 531, 40-47, 2019 | 15 | 2019 |